Alison Long
Director/Board Member at TAYSHA GENE THERAPIES, INC.
Net worth: - $ as of 30/04/2024
Alison Long active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Director/Board Member | 01/11/2023 | - |
| Independent Dir/Board Member | 01/11/2023 | - |
Career history of Alison Long
Former positions of Alison Long
| Companies | Position | Start | End |
|---|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 15/12/2021 | 01/06/2022 |
| FREELINE THERAPEUTICS HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 01/10/2021 | 01/11/2021 |
Training of Alison Long
| University of the Witwatersrand | Doctorate Degree |
| George Mason University | Doctorate Degree |
Statistics
International
| United States | 4 |
| United Kingdom | 2 |
| South Africa | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 2 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| TAYSHA GENE THERAPIES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Alison Long
- Experience